by danka | Apr 21, 2022 | Speakers Biosimilars LatAm - Brazil 2023, Speakers Biosimilars LatAm - Colombia 2022, Speakers Biosimilars LatAm - Colombia 2024
Sartorius, Mexico Business Development Manager Biotechnology Engineer from the National Polytechnic Institute. He was a Culture Chemist at Probiomed. He completed postgraduate studies at the National Autonomous University of Mexico. He is lecturer at UNAM in the...
by danka | Apr 23, 2021 | Speakers Biosimilars Latam - Colombia 2021, Speakers Biosimilars LatAm - Colombia 2024
INNOS, Colombia Director With nearly 15 years of experience in Educational Management, Carlos has led and implemented improvement, change and innovation processes. As an independent consultant, he led the team that prepared the start of activities of ELITE –...
by danka | Apr 16, 2021 | Speakers Biosimilars Latam - Colombia 2021, Speakers Biosimilars LatAm - Colombia 2024, Speakers Biosimilars LatAm - Europe 2024, Speakers Biosimilars LatAm - Global 2025, Speakers Biosimilars LatAm - Mexico 2024
IDCBIS (Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud) Research Leader Pharmaceutical Biotechnology Unit Dr. Bonilla holds a Pharmacy Bachelor’s Degree from the Universidad Nacional de Colombia (2006) and completed her doctoral studies in...
by danka | Mar 16, 2021 | Speakers Biosimilars Latam - Brazil 2021, Speakers Biosimilars Latam - Colombia 2021, Speakers Biosimilars LatAm - Colombia 2024
Cytiva, Argentina Upstream and Cell Culture Sales Specialist Fernando is a Biotechnologist who made his studies at the University of San Martin in Argentina and his thesis was based on cell adhesion. Fernando began his professional career serving as a scientific...
by danka | Jan 25, 2021 | Speakers Biosimilars Latam - Colombia 2020, Speakers Biosimilars LatAm - Colombia 2023, Speakers Biosimilars LatAm - Colombia 2024
Think Tank “Medicines, Information and Power” UNAL, Colombia Founder and Head · Professor of pharmacoepidemiology and clinic pharmacy. · High level technical advisor and policy maker on public health, with emphasis on access to medicines and biotherapeutics. ·...
